标题
Ezatiostat hydrochloride for the treatment of myelodysplastic syndromes
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 24, Issue 5, Pages 725-733
出版商
Informa Healthcare
发表日期
2015-02-28
DOI
10.1517/13543784.2015.1021003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent developments in myelodysplastic syndromes
- (2014) R. Bejar et al. BLOOD
- An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin
- (2014) Soraya Carrancio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study
- (2014) Zoe K. McQuilten et al. CANCER
- Trends in incidence, initial treatment and survival of myelodysplastic syndromes: A population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010
- (2014) Avinash G. Dinmohamed et al. EUROPEAN JOURNAL OF CANCER
- Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905
- (2014) Thomas Prebet et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
- (2013) L. Malcovati et al. BLOOD
- New Strategies in Myelodysplastic Syndromes: Application of Molecular Diagnostics to Clinical Practice
- (2013) Z. Tothova et al. CLINICAL CANCER RESEARCH
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
- (2013) W. W. Pang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidemiology of Myelodysplastic Syndromes
- (2012) Xiaomei Ma AMERICAN JOURNAL OF MEDICINE
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
- (2012) Julie Schanz et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)
- (2012) Azra Raza et al. Journal of Hematology & Oncology
- Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome
- (2012) Naomi Galili et al. Journal of Hematology & Oncology
- A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome
- (2011) Azra Raza et al. CANCER
- Oral ezatiostat HCl (Telintra®, TLK199) and Idiopathic Chronic Neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitor
- (2011) Roger M Lyons et al. Journal of Hematology & Oncology
- Incidence of myelodysplastic syndromes in a Swedish population
- (2010) Anders Rådlund et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial
- (2010) T. de Witte et al. HAEMATOLOGICA
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome
- (2009) A. Raza et al. BLOOD
- Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)
- (2009) P. L. Greenberg et al. BLOOD
- Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults With Myelodysplastic Syndromes: The Alternative Dosing for Outpatient Treatment (ADOPT) Trial
- (2009) David P. Steensma et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra(R), TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
- (2009) Azra Raza et al. Journal of Hematology & Oncology
- A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide
- (2009) S. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search